Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
1
0
0
Metsera, Inc. - Common Stock Share · US59267L1070 · MTSR (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Metsera, Inc. - Common Stock
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 45,69 %
Shares Float 48,15 M
Shares Outstanding 105,38 M
Company Profile for Metsera, Inc. - Common Stock Share
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity. The company was incorporated in 2022 and is headquartered in New York, New York.
Company Data
Name Metsera, Inc. - Common Stock
Company Metsera, Inc.
Symbol MTSR
Website
https://metsera.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US59267L1070
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Christopher Whitten Bernard
Market Capitalization 7 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 3 World Trade Center, 10007 New York City
IPO Date 2025-01-31
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | MTSR |
More Shares
Investors who hold Metsera, Inc. - Common Stock also have the following shares in their portfolio:
